Abstract:BackgroundThe success of clinical trials of selective B cell depletion in patients with relapsing multiple sclerosis (MS) indicates B cells are important contributors to peripheral immune responses involved in the development of new relapses. Such B cell contribution to peripheral inflammation likely involves antibody-independent mechanisms. Of growing interest is the potential that B cells, within the MS central nervous system (CNS), may also contribute to the propagation of CNS-compartmentalized inflammation in progressive (non-relapsing) disease. B cells are known to persist in the inflamed MS CNS and are more recently described as concentrated in meningeal immune-cell aggregates, adjacent to the subpial cortical injury which has been associated with progressive disease. How B cells are fostered within the MS CNS and how they may contribute locally to the propagation of CNS-compartmentalized inflammation remain to be elucidated.MethodsWe considered whether activated human astrocytes might contribute to B cell survival and function through soluble factors. B cells from healthy controls (HC) and untreated MS patients were exposed to primary human astrocytes that were either maintained under basal culture conditions (non-activated) or pre-activated with standard inflammatory signals. B cell exposure to astrocytes included direct co-culture, co-culture in transwells, or exposure to astrocyte-conditioned medium. Following the different exposures, B cell survival and expression of T cell co-stimulatory molecules were assessed by flow cytometry, as was the ability of differentially exposed B cells to induce activation of allogeneic T cells.ResultsSecreted factors from both non-activated and activated human astrocytes robustly supported human B cell survival. Soluble products of pre-activated astrocytes also induced B cell upregulation of antigen-presenting cell machinery, and these B cells, in turn, were more efficient activators of T cells. Astrocyte-soluble factors could support survival and activation of B cell subsets implicated in MS, including memory B cells from patients with both relapsing and progressive forms of disease.ConclusionsOur findings point to a potential mechanism whereby activated astrocytes in the inflamed MS CNS not only promote a B cell fostering environment, but also actively support the ability of B cells to contribute to the propagation of CNS-compartmentalized inflammation, now thought to play key roles in progressive disease.

B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers

Induction of brain‐infiltrating T‐bet–expressing B cells in multiple sclerosis

T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities

The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis

T cells in the pathogenesis of multiple sclerosis and related therapy

B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target

The Immune Pathogenesis of Multiple Sclerosis

The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders

Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis

Impact of B cells to the pathophysiology of multiple sclerosis

Anti‐B cell therapies in multiple sclerosis

The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis

Distinct Effector Programs of Brain-Homing CD8+ T Cells in Multiple Sclerosis

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

Recent advances in understanding the pathogenesis and biological treatment of multiple sclerosis

Identification of essential modules regulating T cell migration to the central nervous system in multiple sclerosis

Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis

Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis